NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Super Micro Computer
SMCI
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
VYGR Voyager Therapeutics
- 4.010
- -0.120-2.91%
Close Feb 27 16:00 ET
- 4.010
- 0.0000.00%
Post 16:11 ET
219.05MMarket Cap6.08P/E (TTM)
4.130High4.000Low245.69KVolume4.130Open4.130Pre Close997.76KTurnover0.55%Turnover Ratio1.35P/E (Static)54.63MShares10.66052wk High0.66P/B179.18MFloat Cap4.00052wk Low--Dividend TTM44.68MShs Float31.910Historical High--Div YieldTTM3.15%Amplitude2.460Historical Low4.061Avg Price1Lot Size
Voyager Therapeutics Stock Forum
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.
No comment yet